搜索临床试验以:Local Tailoring
总计73223个结果
-
Università Vita-Salute San RaffaeleIRCCS San Raffaele; Associazione Italiana per la Ricerca sul Cancro尚未招聘乳腺癌女性 | 小叶性乳腺癌 | Luminal A 乳腺癌 | 宠物/核磁共振 | 腋窝淋巴结肿大
-
University Hospital, AkershusOslo University Hospital; Oncosyne AS招聘中
-
Jonsson Comprehensive Cancer CenterEli Lilly and Company招聘中
-
Chun ChaoPatient-Centered Outcomes Research Institute招聘中
-
The Netherlands Cancer InstituteRadboud University Medical Center招聘中
-
Moscow City Oncology Hospital No. 62完全的子宫内膜肿瘤 | 子宫内膜癌 | 前哨淋巴结 | 子宫内膜 子宫内膜样腺癌 | 子宫内膜腺癌 | 子宫切除术 | 子宫内膜癌 I 期 | 腹腔镜子宫切除术 | 子宫内膜癌 II 期俄罗斯联邦
-
NRG OncologyNational Cancer Institute (NCI); Canadian Cancer Trials Group暂停
-
Borstkanker Onderzoek GroepNovartis; Philips Healthcare主动,不招人
-
University of California, MercedNational Cancer Institute (NCI)完全的
-
University of SevilleMaastricht University; Delegación del Gobierno para el Plan Nacional sobre Drogas完全的
-
British Columbia Cancer AgencyHoffmann-La Roche主动,不招人
-
UMC UtrechtRudolf Magnus Institute - University of Utrecht未知
-
University of SevilleAristotle University Of Thessaloniki; Hospitales Universitarios Virgen del Rocío; Salumedia Tecnologias 和其他合作者完全的
-
University of SevilleMaastricht University; Junta de Andalucía完全的
-
Yunnan Cancer HospitalAffiliated Cancer Hospital of Shantou University Medical College尚未招聘乳腺癌 | 淋巴结转移 | 数字病理学 | 虚拟染色
-
Changzhi People's Hospital Affiliated to Changzhi...招聘中
-
Xuanwu Hospital, BeijingBioray Laboratories尚未招聘
-
HistoSonics, Inc.尚未招聘肝脏肿瘤 | 原发性肝癌 | 继发性肝癌 | 良性肝肿瘤 | 肿瘤肝
-
Gilead SciencesGOG Foundation; European Network of Gynaecological Oncological Trial Groups (ENGOT)尚未招聘
-
First Affiliated Hospital of Wenzhou Medical University招聘中
-
Centre Hospitalier Universitaire de la Réunion招聘中
-
Shenzhen TargetRx, Inc.Sir Run Run Shaw Hospital尚未招聘非小细胞肺癌 | 晚期实体瘤 | 血液系统恶性肿瘤
-
Second Affiliated Hospital of Guangzhou Medical...招聘中
-
Merck Sharp & Dohme LLC尚未招聘
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Andy Hill Cancer Research Endowment (CARE) Fund尚未招聘
-
Wuhan Union Hospital, China尚未招聘评价呋喹替尼和吡非尼酮联合抗PD-1抗体治疗结直肠癌的疗效 | 评估吡非尼酮是否可以重塑结直肠癌的肿瘤微环境 | 据报道,呋喹替尼和抗 PD-1 抗体的组合可改善结直肠癌患者的预后
-
Shengjing HospitalHuazhong University of Science and Technology; Tianjin Medical University General Hospital; Zhongda... 和其他合作者尚未招聘肝脓肿 | TACE | HCC - 肝细胞癌